Company intelligence / Profile preview

Arirang

Ownership: Private
Development stage: Other

Overview

Arirang Biotech develops and manufactures biologic therapies using a proprietary plant-based platform. The company focuses on accelerating drug development from research through clinical trials to commercialization by offering scalable, cost-effective solutions for producing high-quality biologics. Their technology leverages plants as bioreactors for rapid and efficient manufacturing of therapeutic proteins and other biological products.

Therapeutic areas: Other
Modalities: BiologicRecombinant proteinPlant-based biologics
Industry: Biotech

Beyond the preview

Go deeper on Arirang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arirang.

Explore the full profile